Lixte Biotechnology Holdings, INC. (LIXT) — S-1/A Filings

All S-1/A filings from Lixte Biotechnology Holdings, INC.. Browse 4 S-1/A reports with AI-powered summaries and risk analysis.

S-1/A Filings (4)

LIXTE Amends S-1/A for Public Offering, Signals Capital Raise — Jul 10, 2025 Risk: medium
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) filed an S-1/A on July 10, 2025, indicating an amendment to its registration statement for a proposed public offering.
LIXTE Amends S-1 for Public Offering, Updates Executive Info — Jun 24, 2025 Risk: high
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) filed an S-1/A on June 24, 2025, as an amendment to its initial S-1 registration statement, indicating a proposed publ
Lixte Biotechnology Holdings Files S-1/A Amendment — Apr 9, 2025 Risk: medium
Lixte Biotechnology Holdings, Inc. filed an S-1/A amendment on April 9, 2025, for a registration statement. The company, previously known as SRKP 7 INC, is inco
Lixte Biotechnology Files S-1/A Amendment — Nov 1, 2024 Risk: medium
Lixte Biotechnology Holdings, Inc. filed an S-1/A amendment on November 1, 2024, to its registration statement. The company, incorporated in Delaware, is involv

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX